glp gip glucagon & cagrilintide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Identification and utility exploration of

Join me as I interview medical experts, renowned thought leaders and innovators of all types, helping you and bringing you information to achieve optimal performance and longevity

A 2025 Nature Communications paper mapped the binding to the disordered transactivation domain of p53, adding structural detail to how FOXO4-DRI engages its target

HUBERMAN: My whole purpose in doing this episode is to highlight how these different molecules ought to work, how they've been shown to work in animal models, and therefore how they might be working in humans

Therapeutic Research Protocol Dose: 10 20 mg (= 3061 clicks) Duration: 4 6 weeks Frequency: Daily Cycle Interval: 4-week interval Goal / Description: Modeled on extended NNMT inhibition protocols in DIO models